Background: Calcitonin gene–related peptide (CGRP) receptor antagonist (collectively known as gepant) have emerged as effective therapies for both acute migraine treatment and preventive management.
Global pharmaceutical company Pfizer has announced the launch of a Rimegepant Orally Disintegrating Tablet (ODT) in India for acute treatment of migraine in adults with a previous insufficient ...
ED Cracks Down on Punjab Drug Cartel: Key Middleman Abhishek Kumar Arrested in Rs 3.75 Crore Money Laundering Probe (11-12-2025) ...
Pfizer launches new migraine drug in India (Image Source: Freepik) Drug maker Pfizer on Monday introduced a new migraine treatment in India, offering hope to millions who struggle with severe and ...
Pfizer has launched Rimegepant ODT, a new migraine treatment in India. It offers rapid, lasting relief and targets patients who do not respond to conventional drugs. The medication dissolves without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback